Advertisement

Topics

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) Company Profile

21:31 EDT 23rd September 2017 | BioPortfolio


News Articles [7690 Associated News Articles listed on BioPortfolio]

Johnson & Johnson, HHS partner on influenza

Johnson & Johnson announced that Janssen Research & Development are collaborating with the HHS’ Office of the Assistant Secretary for Preparedness and Response (ASPR) to develop a comprehens...

Proteros teams up with Johnson & Johnson Innovation on sub-class of epigenetic targets

Proteros biostructures GmbH announced today that the company has entered into a collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, on a sub-cl...

Johnson & Johnson ordered to pay $110m in US talcum powder cancer lawsuit

A Missouri jury has ordered pharmaceutical firm Johnson & Johnson (J&J) to pay over $110m as compensation to a woman who says she developed ovarian cancer after using the company's talc-based products...

Johnson & Johnson Announces Expected Settlement of Actelion Tender Offer

Johnson & Johnson announced that, with today's receipt of approval of the proposed acquisition of Actelion Ltd from the European Commission (EC), all regulatory approvals required to complete the tran...

Johnson & Johnson reveals Justice Department investigations

Johnson & Johnson revealed in a filing with the Securities and Exchange Commission (SEC) that the US…

Johnson & Johnson tops 2Q profit forecasts

This Tuesday, Sept. 13, 2016, file photo, shows Johnson & Johnson Band-Aid brand bandages in Surfside, Fla.

Johnson & Johnson Announces Quarterly Dividend for First Quarter 2013

NEW BRUNSWICK, N.J., Jan. 2, 2013 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2013 of $0.61 per ...

Johnson Johnson caught in another scandal, forced to pay $33 million ...

Johnson & Johnson is set to dole out up to $33 million in settlement with 42 states over allegations that a subsidiary of the pharmaceutical drug giant sold nonprescription medicines that did not ...

PubMed Articles [5844 Associated PubMed Articles listed on BioPortfolio]

Cefepime Associated With Phenytoin Induced Stevens-Johnson Syndrome.

We describe a recent case of Stevens-Johnson Syndrome. A 49-year-old man was admitted to the Intensive Care Unit of an Anaesthesia and Resuscitation Department because of a Fournier gangrene that deri...

Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials.

Lamotrigine is an antiepileptic drug used for the treatment of epilepsy, bipolar disorder and numerous off-label uses. The development of rash significantly affects its use. The most concerning of the...

Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications Following Use of Cold Medicine in a Brazilian Population.

Describing the association with human leukocyte antigen (HLA) alleles could facilitate the understanding of increased risk factors for development of Stevens-Johnson syndrome (SJS) and toxic epidermal...

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working Group.

Toxic epidermal necrolysis (TEN) and Stevens-Johnson Syndrome (SJS) are rare, acute, life-threatening dermatologic disorders involving the skin and mucous membranes. Research into these conditions is ...

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology-Thirty Years of Progress but Still Much to Be Done.

Although rare, Stevens-Johnson syndrome and toxic epidermal necrolysis remain among the most devastating of acute conditions involving the skin. In the past 30 years, tremendous progress has been made...

Clinical Trials [3152 Associated Clinical Trials listed on BioPortfolio]

Stevens-Johnson Syndrome Antimicrobial

Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacteri...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Patients diagnosed with Stevens-Johnson syndrome and Toxic Epidermal Necrolysis were confirmed based on the investigators national diagnostic criteria. Patients who meet all inclusion crit...

Extracorporeal Photopheresis Pilot Study

ECP will be given to the patients [UVAR®XTS TM Therakos system, Johnson & Johnson] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allow...

Companies [5472 Associated Companies listed on BioPortfolio]

Johnson & Johnson Pharmaceutical Research and Development, L.L.C.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) is a wholly-owned subsidiary of Johnson & Johnson, the world's most broadly based producer of health care ...

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) is a wholly-owned subsidiary of Johnson & Johnson, the world's most broadly based producer of health care ...

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD)

Janssen(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) is headquartered in Raritan, New Jersey (USA), and has nine sites throughout Europe and the United States. J&JPRD employs appro...

Johnson & Johnson Innovation

The London Innovation Centre is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Limited. Johnson & Johnson Innovation focuses on accelerating early i...

More Information about "Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD)" on BioPortfolio

We have published hundreds of Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) news stories on BioPortfolio along with dozens of Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) Clinical Trials and PubMed Articles about Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) Companies in our database. You can also find out about relevant Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record